Compositions and Methods for Enhancing Anti-Viral TherapiesCALGARY, Alberta, March 23, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the...
Basel, 23 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the donation of additional medicines and diagnostics...
IMA203 TCR-T candidate targeting PRAME demonstrated a 50% objective response rate across different solid tumor types in an interim update...
Represents World’s First Surveillance Solutions for Investigational Use in Xenotransplantation Research and Post-Xenotransplant Clinical MonitoringSOUTH SAN FRANCISCO, Calif., March 23,...
OVAL top-line data for ofra-vec progression free survival (PFS) primary endpoint expected in 2H 2022; with positive results, VBL anticipates...
LONDON, March 23, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”) today announced that...
AUSTIN, Texas, March 23, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics...
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that...
NEW YORK and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 23, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused...
Jury Finds Natera Falsely Advertised its Prospera Kidney Transplant TechnologySOUTH SAN FRANCISCO, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- CareDx,...
Today, GN Store Nord A/S is hosting a Meet-the-Management event in Copenhagen, Denmark, for investors and analysts. The event will...
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. Cambridge,...
Engages Apaton Finance to Provide Investor Relations Services in EuropeVancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - NervGen Pharma...
AccuRoute’s 2022 Release features expanded Electronic Medical Records (EMR) integrations, Multifunction Printer (MFP) integrations, and learned automation capabilities AUSTIN, Texas--(BUSINESS...
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #Benzinga--Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health...
Glenn Boehnlein, Kevin King and Mary Kay Ladone Appointed as Independent Directors GOLETA, California--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical...
LOS ANGELES, CA / ACCESSWIRE / March 22, 2022 / CompuMed, Inc. (OTC PINK:CMPD), a leader in providing diagnostic telemedicine,...
MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with...
REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and...